FDA Warning Letter — Pharmakon Compounding Pharmacy, Inc.

Case 523191 — FEI 3012248018

The FDA took a Warning Letter action against Pharmakon Compounding Pharmacy, Inc. on September 7, 2017 (Noblesville, IN). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Pharmakon Compounding Pharmacy, Inc.
Date
September 7, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
Noblesville, IN (United States)